COVID-19 study links strict social distancing to much lower chance of infection

Using public transportation, visiting a place of worship, or otherwise traveling from the home is associated with a significantly higher likelihood of testing positive with the coronavirus SARS-CoV-2, while practicing strict social distancing is associated with a markedly lower likelihood, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.

For their analysis, the researchers surveyed a random sample of more than 1,000 people in the state of Maryland in late June, asking about their social distancing practices, use of public transportation, SARS-CoV-2 infection history, and other COVID-19-relevant behaviors. They found, for example, that those reporting frequent public transport use were more than four times as likely to report a history of testing positive for SARS-CoV-2 infection, while those who reported practicing strict outdoor social distancing were just a tenth as likely to report ever being SARS-CoV-2 positive.

The study is believed to be among the first large-scale evaluations of COVID-19-relevant behaviors that is based on individual-level survey data, as opposed to aggregated data from sources such as cellphone apps.

The results were published online on September 2 in Clinical Infectious Diseases.

"Our findings support the idea that if you're going out, you should practice social distancing to the extent possible because it does seem strongly associated with a lower chance of getting infected," says study senior author Sunil Solomon, MBBS, PhD, MPH, an associate professor in the Bloomberg School's Department of Epidemiology and an associate professor of medicine at Johns Hopkins School Medicine. "Studies like this are also relatively easy to do, so we think they have the potential to be useful tools for identification of places or population subgroups with higher vulnerability."

The novel coronavirus SARS-CoV-2 has infected nearly 27 million people around the world, of whom some 900,000 have died, according to the World Health Organization. In the absence of a vaccine, public health authorities have emphasized practices such as staying at home, and wearing masks and maintaining social distancing while in public. Yet there hasn't been a good way to monitor whether - and among which groups - such practices are being followed.

Solomon and colleagues, including first author Steven Clipman, a PhD candidate in the Bloomberg School's Department of International Health, quickly accessed willing survey participants via a company that maintains a large nationwide pool of potential participants as a commercial service for market research. The 1,030 people included in the study were all living in Maryland, which has logged more than 113,000 SARS-CoV-2 confirmed cases and nearly 3,700 confirmed deaths, according to the Maryland Department of Health.

The researchers asked the survey participants questions about recent travel outside the home, their use of masks, social distancing and related practices, and any confirmed infection with SARS-CoV-2 either recently or at all.

The results indicated that 55 (5.3 percent) of the 1,030 participants had tested positive for SARS-CoV-2 infection at any time, while 18 (1.7 percent) reported testing positive in the two weeks before they were surveyed.

The researchers found that when considering all the variables they could evaluate, spending more time in public places was strongly associated with having a history of SARS-CoV-2 infection. For example, an infection history was about 4.3 times more common among participants who stated that they had used public transportation more than three times in the prior two weeks, compared to participants who stated they had never used public transportation in the two-week period.

An infection history also was 16 times more common among those who reported having visited a place of worship three or more times in the prior two weeks, compared to those who reported visiting no place of worship during the period. The survey did not distinguish between visiting a place of worship for a religious service or other purposes, such as a meeting, summer camp or meal.

Conversely, those who reported practicing social distancing outdoors "always" were only 10 percent as likely to have a SARS-CoV-2 history, compared to those who reported "never" practicing social distancing.

An initial, relatively simple analysis linked many other variables to SARS-CoV-2 infection history, including being Black or Hispanic. But a more sophisticated, "multivariable" analysis suggested that many of these apparent links were largely due to differences in movement and social distancing.

"When we adjusted for other variables such as social distancing practices, a lot of those simple associations went away, which provides evidence that social distancing is an effective measure for reducing SARS-CoV-2 transmission," Clipman says.

The data indicated a greater adoption of social distancing practices among some groups who are especially vulnerable to serious COVID-19 illness, suggesting that they were relatively aware of their vulnerability. For example, 81 percent of over-65 participants reported always practicing social distancing at outdoor activities, while only 58 percent of 18-24 year olds did so.

The results are consistent with the general public health message that mask-wearing, social distancing, and limiting travel whenever possible reduce SARS-CoV-2 transmission. The researchers suggest, though, that studies such as these, employing similarly rapid surveys of targeted groups, could also become useful tools for predicting where and among which groups infectious diseases will spread most quickly.

"We did this study in Maryland in June, and it showed among other things that younger people in the state were less likely to reduce their infection risk with social distancing--and a month later a large proportion of the SARS-CoV-2 infections detected in Maryland was among younger people," says Solomon. "So, it points to the possibility of using these quick, inexpensive surveys to predict where outbreaks are going to happen based on behaviors, and then mobilizing public health resources accordingly."

Solomon and his team are now conducting similar surveys in other states and are studying the surveys' potential as predictive epidemiological tools.

Steven J Clipman, Amy P Wesolowski, Dustin G Gibson, Smisha Agarwal, Anastasia S Lambrou, Gregory D Kirk, Alain B Labrique, Shruti H Mehta, Sunil S Solomon.
Rapid real-time tracking of non-pharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study.
Clinical Infectious Diseases, 2020. doi: 10.1093/cid/ciaa1313.

Most Popular Now

Therapy using dual immune system cells effectively…

A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was ...

Cleveland Clinic study suggests steroid nasal spra…

A recent Cleveland Clinic study found that patients who regularly use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including a 20 to 2...

How to develop new drugs based on merged datasets

Polymorphs are molecules that have different molecular packing arrangements despite identical chemical compositions. In a recent paper, researchers at GlaxoSmithKline (GS...

New drug combination effective against SARS-CoV-2 …

More countries with greater resources are opening up for a more normal life. But COVID-19 and the SARS-CoV-2 virus are still a significant threat in large parts of the wo...

Sanofi to focus its COVID-19 development efforts o…

Recent positive interim results of Sanofi's mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the company's platform robust capabilities and strategy in mRNA...

Discovery of mechanics of drug targets for COVID-1…

A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases suc...

Phase II/III trial shows Ronapreve™ (casirivimab a…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive data from the phase II/III 2066 study, investigating Ronapreve™ (casirivimab and imdevimab) in patients hospit...

Pfizer and BioNTech receive first U.S. FDA Emergen…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the P...

AZD7442 request for Emergency Use Authorization fo…

AstraZeneca has submitted a request to the US Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) for AZD7442, its long-acting antibody (LAAB) com...

Pfizer and BioNTech receive CHMP positive opinion …

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

Boehringer Ingelheim acquires Abexxa Biologics to …

Boehringer Ingelheim announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology r...

GSK welcomes WHO recommendation for broad roll-out…

GlaxoSmithKline (GSK) plc welcomes and applauds the WHO recommendation for the broader deployment of GSK's RTS,S malaria vaccine to reduce childhood illness and deaths fr...